Clinical exome sequencing data from patients with inborn errors of immunity: Cohort level diagnostic yield and the benefit of systematic reanalysis

Emil E Vorsteveld, Caspar I Van der Made, Sanne P Smeekens, Janneke H Schuurs-Hoeijmakers, Galuh Astuti, Heleen Diepstra, Christian Gilissen, Evelien Hoenselaar, Alice Janssen, Kees van Roozendaal, Jettie Sikkema-van Engelen, Wouter Steyaert, Marjan M Weiss, Helger G Yntema, Tuomo Mantere, Mofareh S AlZahrani, Koen van Aerde, Beata Derfalvi, Eissa Ali Faqeih, Stefanie S V HenrietElise van Hoof, Eman Idressi, Thomas B Issekutz, Marjolijn C J Jongmans, Riikka Keski-Filppula, Ingrid Krapels, Maroeska Te Loo, Catharina M Mulders-Manders, Jaap Ten Oever, Judith Potjewijd, Nora Tarig Sarhan, Marjan C Slot, Paulien A Terhal, Herman Thijs, Anthony Vandersteen, Els K Vanhoutte, Frank van de Veerdonk, Gijs van Well, Mihai G Netea, Annet Simons, Alexander Hoischen*, Rob J W Arts, Else M Bijker, Mariolina Bruno, Willemijn Hobo, Esther Hoppenreijs, Marien I de Jonge, Arjan van Laarhoven, Members of the Radboud University Medical Center multidisciplinary immune-disease board, Radboud University Medical Center multidisciplinary immune-disease board

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Clinical exome sequencing data from patients with inborn errors of immunity: Cohort level diagnostic yield and the benefit of systematic reanalysis'. Together they form a unique fingerprint.

INIS

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Keyphrases